Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[ 35S]thio)triphosphate binding assay

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 3, 2011, Pages 175-185

  Odagaki, Yuji ^a   Kinoshita, Masakazu ^a   Toyoshima, Ryoichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 2 METHYL 4 PHOSPHONOBUTYRIC ACID; 2,2,2 TRIFLUORO N[4 (2 METHOXY PHENOXY)PHENYL]N(3 PYRIDINYLMETHYL)ETHANESULPHONAMIDE; 3 CARBOXY 4 HYDROXYPHENYLGLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 3 HYDROXYPHENYLGLYCINE; 4 CARBOXYPHENYLGLYCINE; ALPHA CYCLOPROPYL 4 PHOSPHONOPHENYLGLYCINE; ALPHA METHYL 4 PHOSPHONOPHENYLGLYCINE; ALPHA METHYL 4 SULPHONOPHENYLGLYCINE; EGLUMETAD; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; IONOTROPIC RECEPTOR AGONIST; KAINIC ACID; LY 487379; MAGNESIUM CHLORIDE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N ACETYLASPARTYLGLUTAMIC ACID; N ETHYLMALEIMIDE; N METHYL DEXTRO ASPARTIC ACID; PHOSPHOSERINE; QUISQUALIC ACID; SODIUM CHLORIDE; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN CORTEX; CONCENTRATION RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLMALEIMIDE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SULFUR RADIOISOTOPES; TIME FACTORS;

RATTUS; TRIFLUORO;

EID: 80051602072     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00705.x     Document Type: Article

References (55)

1. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61.
2. Conn PJ, Pin J-P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37.
3. Pin J-P, Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr Drug Targets CNS Neurol Disord 2002;1:297-317.
4. Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010;50:295-322. Doi:.
5. Marek GJ. Metabotropic glutamate 2/3 receptors as drug targets. Curr Opin Pharmacol 2004;4:18-22. Doi:.
6. Palucha A, Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 2007;115:116-47. Doi:.
7. Witkin JM, Marek GJ, Johnson BG, Schoepp DD. Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 2007;6:87-100.
8. Krivoy A, Fischel T, Weizmann A. The possible involvement of metabotropic glutamate receptors in schizophrenia. Eur Neuropsychopharmacol 2008;18:395-405. Doi:.
9. Pilc A, Chaki S, Nowak G, Witkin JM. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 2008;75:997-1006. Doi:.
10. Wierońska JM, Pilc A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem Int 2009;55:85-97. Doi:.
11. Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res 2006;326:483-504. Doi:.
12. Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG et al. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid (LY354740): a potent selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 1997;40:528-37. Doi:.
13. Helton DD, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 1998;284:651-60.
14. Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998;281:1349-52.
15. Cartmell J, Monn JA, Schoepp DD. The metabotropic glutamate receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 1999;291:161-70.
16. Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 1999;38:1831-9.
17. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA. Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003;117:697-706. Doi:.
18. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 2007;13:1102-7. Doi:.
19. Dunayevich E, Erickson J, Levine L, Landbloom R, Schoepp DD, Tollefson GD. Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorders. Neuropsychopharmacology 2008;33:1603-10. Doi:.
20. Nishi N, Odagaki Y, Koyama T. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes. Br J Pharmacol 2000;130:1664-70.
21. Odagaki Y, Nishi N, Koyama T. Stimulation of high-affinity GTPase activity through group II metabotropic glutamate receptors in rat hippocampal and striatal membranes. Jpn J Pharmacol 2000;84:399-404.
22. 35S]GTPγS binding assay: approaches and applications in pharmacology. Life Sci 2003; 74:489-508. Doi:.
23. 35S]GTPγS binding in rat hippocampal membranes. J Pharmacol Sci 2005;98:66-76.
24. b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol Sci 1993;14:237-9.
25. Johnson MP, Baez M, Jagdmann GE Jr, Britton TC, Large TH, Callagaro DO et al. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2, 2, 2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine. J Med Chem 2003;46:3189-92. Doi:.
26. 35S]-GTPγS binding. Br J Pharmacol 1997;121:1203-9.
27. 2 receptor-transfected cell membranes. Br J Pharmacol 1998;123:497-504.
28. 35S]GTPγS binding assessment of metabotropic glutamate receptor standards in Chinese hamster ovary cell lines expressing the human metabotropic receptor subtypes 2 and 4. Neuropharmacology 1998;37:179-87.
29. Schaffhauser H, Rowe BA, Morales S, Chavez-Noriega LE, Yin R, Jachec C et al. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol Pharmacol 2003;64:798-810.
30. Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP et al. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 1999;42:1027-40. Doi:.
31. Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S et al. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 1997;36:1-11.
32. Ito I, Kohda A, Tanabe S, Hirose E, Hayashi M, Mitsunaga S et al. 3, 5-Dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors. Neuroreport 1992;3:1013-6.
33. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP et al. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 1998;37:1-12.
34. Ornstein PL, Bleisch TJ, Arnold MB, Kennedy JH, Wright RA, Johnson BG et al. 2-Substituted (2SR)-2-amino-2-((1SR, 2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. J Med Chem 1998;41:358-78. Doi:.
35. Thomas NK, Jane DE, Tse H-W, Watkins JC. α-Methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists. Neuropharmacology 1996;35:637-42.
36. Jane DE, Thomas NK, Tse H-W, Watkins JC. Potent antagonists at the l-AP4- and (1S, 3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology 1996;35:1029-35.
37. Ma D, Tian H, Sun H, Kozikowski AP, Pshenichkin S, Wroblewski JT. Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists. Bioorg Med Chem Lett 1997;7:1195-7.
38. Pellicciari R, Luneia R, Costantino G, Marinozzi M, Natalini B, Jakobsen P et al. 1-Aminoindan-1, 5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. J Med Chem 1995;38:3717-9. Doi:.
39. Moroni F, Lombardi G, Thomsen C, Leonardi P, Attucci S, Peruginelli F et al. Pharmacological characterization of 1-aminoindan-1, 5-dicarboxylic acid, a potent mGluR1 antagonist. J Pharmacol Exp Ther 1997;281:721-9.
40. 3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology 1999;38:1519-29.
41. Odagaki Y, Fuxe K. Agonist-induced high-affinity GTP hydrolysis as an index of receptor-mediated G protein activation in mammalian brain membranes. In: Challis RAJ (ed.). Methods in Molecular Biology, Vol. 83, Receptor Signal Transduction Protocols. Humana Press, Totowa, 1997;133-41.
42. Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N et al. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for l-2-amino-4-phosphonobutyrate. J Biol Chem 1993;268:11868-73.
43. Hayashi Y, Tanabe Y, Aramori I, Masu M, Shimamoto K, Ohfune Y et al. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br J Pharmacol 1992;107:539-43.
44. Tanabe Y, Nomura A, Masu M, Shigemoto R, Mizuno N, Nakanishi S. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. J Neurosci 1993;13:1372-8.
45. Cavanni P, Pinnola V, Mugnaini M, Trist D, Van Amsterdam FTM, Ferraguti F. Pharmacological analysis of carboxyphenylglycines at metabotropic glutamate receptors. Eur J Pharmacol 1994;269:9-15.
46. Hayashi Y, Sekiyama N, Nakanishi S, Jane DE, Sunter DC, Birse EF et al. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. J Neurosci 1994;14:3370-7.
47. 3H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors. Neuropharmacology 2000;39:1700-6.
48. Wroblewska B, Wroblewski JT, Pshenichkin S, Surin A, Sullivan SE, Neale JH. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 1997;69:174-81.
49. Dominguenz C, Prieto L, Valli MJ, Massey SM, Bures M, Wright RA et al. Methyl substitution of 2-aminobicyclo[3.1.0]hexane 2, 6-dicarboxylate (LY354740) determines functional activity at metabotropic glutamate receptors: identification of a subtype selective mGlu2 receptor agonist. J Med Chem 2005;48:3605-12. Doi:.
50. 39, a guanine nucleotide-binding protein from brain. Location and function. J Biol Chem 1987;262:4501-7.
51. Shinoda M, Katada T, Ui M. Selective coupling of purified α-subunits of pertussis toxin-substrate GTP-binding proteins to endogenous receptors in rat brain membranes treated with N-ethylmaleimide. Cell Signal 1990;2:403-14.
52. 2+ channels by PTX-sensitive G-proteins is blocked by N-ethylmaleimide in rat sympathetic neurons. J Neurosci 1994;14:7109-16.
53. B receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramine, and benzalkonium chloride in rat cerebral cortical membranes. J Neural Transm 2000;107:1101-16.
54. Kilpatrick BF, De Lean A, Caron MG. Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides. Mol Pharmacol 1982;22:298-303.
55. 2-adrenoceptors from GTP-binding proteins by N-ethylmaleimide. J Neurochem 1987;49:1894-901.